The AABB 32nd edition Standards have redefined the criteria for the ABO second sample. This criterion is particularly challenging to implement at facilities serving pediatric populations due to the desire to avoid excess needle sticks, as well as concerns about iatrogenic blood loss in these smallest of patients. We will discuss the changes in the standard with a focus on neonatal and pediatric application and present implementation strategies from three different large academic neonatal and pediatric hospitals. Each of the institutions are in varied stages of implementation: preparation, action, and maintenance. Examples of a failure mode effects analysis, electronic health record decision support options and educational materials will be provided. We will also discuss mislabeled specimen challenges in pediatrics. Recommendations that will be applicable to all patient populations will be provided.
Compare three methods of ABO second sample implementation in pediatrics
Recognize impact of the ABO second sample in certain neonatal and pediatric patient populations
Evaluate pros and cons of each implementation and potential impact on Group O RBC usage